Asialoglycoprotein receptor (ASGPR) was used to detect CTCs in HCC patients, and CTCs were identified in 81–89% of HCC patients (≥0.2 CTCs/ml blood), respectively44,45. The gene discussed is ASGR1; the disease is hepatocellular carcinoma.